Hong Kong · Delayed Price · Currency is HKD Charmacy Pharmaceutical Statistics
Total Valuation
HKG:2289 has a market cap or net worth of HKD 628.56 million. The enterprise value is 1.82 billion.
| Market Cap | 628.56M |
| Enterprise Value | 1.82B |
Important Dates
The last earnings date was Friday, March 27, 2026.
| Earnings Date | Mar 27, 2026 |
| Ex-Dividend Date | May 27, 2026 |
Share Statistics
HKG:2289 has 108.00 million shares outstanding. The number of shares has decreased by -0.01% in one year.
| Current Share Class | 108.00M |
| Shares Outstanding | 108.00M |
| Shares Change (YoY) | -0.01% |
| Shares Change (QoQ) | -0.01% |
| Owned by Insiders (%) | 31.97% |
| Owned by Institutions (%) | n/a |
| Float | 27.00M |
Valuation Ratios
The trailing PE ratio is 12.21.
| PE Ratio | 12.21 |
| Forward PE | n/a |
| PS Ratio | 0.13 |
| PB Ratio | 0.92 |
| P/TBV Ratio | 1.04 |
| P/FCF Ratio | 2.14 |
| P/OCF Ratio | 2.09 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 10.17, with an EV/FCF ratio of 6.22.
| EV / Earnings | 35.39 |
| EV / Sales | 0.37 |
| EV / EBITDA | 10.17 |
| EV / EBIT | 12.45 |
| EV / FCF | 6.22 |
Financial Position
The company has a current ratio of 1.09, with a Debt / Equity ratio of 2.98.
| Current Ratio | 1.09 |
| Quick Ratio | 0.63 |
| Debt / Equity | 2.98 |
| Debt / EBITDA | 11.41 |
| Debt / FCF | 6.97 |
| Interest Coverage | 2.31 |
Financial Efficiency
Return on equity (ROE) is 7.49% and return on invested capital (ROIC) is 5.60%.
| Return on Equity (ROE) | 7.49% |
| Return on Assets (ROA) | 2.22% |
| Return on Invested Capital (ROIC) | 5.60% |
| Return on Capital Employed (ROCE) | 19.38% |
| Weighted Average Cost of Capital (WACC) | 1.56% |
| Revenue Per Employee | 5.76M |
| Profits Per Employee | 60,795 |
| Employee Count | 849 |
| Asset Turnover | 1.18 |
| Inventory Turnover | 5.58 |
Taxes
In the past 12 months, HKG:2289 has paid 20.07 million in taxes.
| Income Tax | 20.07M |
| Effective Tax Rate | 28.05% |
Stock Price Statistics
The stock price has decreased by -24.90% in the last 52 weeks. The beta is -0.88, so HKG:2289's price volatility has been lower than the market average.
| Beta (5Y) | -0.88 |
| 52-Week Price Change | -24.90% |
| 50-Day Moving Average | 5.81 |
| 200-Day Moving Average | 6.12 |
| Relative Strength Index (RSI) | 36.95 |
| Average Volume (20 Days) | n/a |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, HKG:2289 had revenue of HKD 4.88 billion and earned 51.49 million in profits. Earnings per share was 0.48.
| Revenue | 4.88B |
| Gross Profit | 373.92M |
| Operating Income | 146.38M |
| Pretax Income | 71.56M |
| Net Income | 51.49M |
| EBITDA | 169.31M |
| EBIT | 146.38M |
| Earnings Per Share (EPS) | 0.48 |
Balance Sheet
The company has 850.91 million in cash and 2.04 billion in debt, with a net cash position of -1.19 billion or -11.05 per share.
| Cash & Cash Equivalents | 850.91M |
| Total Debt | 2.04B |
| Net Cash | -1.19B |
| Net Cash Per Share | -11.05 |
| Equity (Book Value) | 685.90M |
| Book Value Per Share | 6.35 |
| Working Capital | 311.35M |
Cash Flow
In the last 12 months, operating cash flow was 301.45 million and capital expenditures -8.32 million, giving a free cash flow of 293.14 million.
| Operating Cash Flow | 301.45M |
| Capital Expenditures | -8.32M |
| Depreciation & Amortization | 23.73M |
| Net Borrowing | -155.90M |
| Free Cash Flow | 293.14M |
| FCF Per Share | 2.71 |
Margins
Gross margin is 7.66%, with operating and profit margins of 3.00% and 1.06%.
| Gross Margin | 7.66% |
| Operating Margin | 3.00% |
| Pretax Margin | 1.47% |
| Profit Margin | 1.06% |
| EBITDA Margin | 3.47% |
| EBIT Margin | 3.00% |
| FCF Margin | 6.01% |
Dividends & Yields
This stock pays an annual dividend of 0.35, which amounts to a dividend yield of 5.93%.
| Dividend Per Share | 0.35 |
| Dividend Yield | 5.93% |
| Dividend Growth (YoY) | 48.27% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 173.97% |
| Buyback Yield | 0.01% |
| Shareholder Yield | 5.94% |
| Earnings Yield | 8.19% |
| FCF Yield | 46.64% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
HKG:2289 has an Altman Z-Score of 1.51 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.51 |
| Piotroski F-Score | 6 |